SCHEMBL20152219

SCHEMBL20152219

c1ccc(-c2nc(-c3ccccc3)n(-n3c4ccccc4c4c5c6ccccc6n(-n6c(-c7ccccc7)nc(-c7ccccc7)c6-c6ccccc6)c5ccc43)c2-c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
POLB P06746 1/20 0.38
HSD17B10 Q99714 1/20 0.38
USP2 O75604 1/20 0.36
MAPK1 P28482 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
BCHE P06276 1/20 0.35
ACHE P22303 1/20 0.35
ADORA2A P29274 1/20 0.35
NUDT1 P36639 1/20 0.35
MAPT P10636 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
RXFP1 Q9HBX9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20152197 0.83 KDM4E (0.54) HPGDKDM4EALDH1A1SMN1; SMN2KMT2A
SCHEMBL4597351 0.82 BCHE (0.45) HPGDKDM4EALDH1A1SMN1; SMN2KMT2A
SCHEMBL20152184 0.76 BCHE (0.47) KMT2AMEN1BCHEACHEMAPT
SCHEMBL20152195 0.74 BCHE (0.48) KDM4EKMT2AMEN1L3MBTL1BCHE
SCHEMBL7049584 0.71 ALDH1A1 (0.43) HPGDKDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL6362990 0.70 NPSR1 (0.61) HPGDKDM4EALDH1A1SMN1; SMN2POLB
SCHEMBL11508710 0.70 PTGS2 (0.56) SMN1; SMN2NPSR1
SCHEMBL4869355 0.69 ADORA2A (0.46) KDM4EALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL10033037 0.68 GAA (0.51) HPGDKDM4EALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL9888858 0.68 BCHE (0.47) KDM4EKMT2AMEN1L3MBTL1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662196-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-05-26 US disclosed
US-20180134718-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2018-05-17 US disclosed
US-20180134718-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662196-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, SLCO4C1 HPGD 1331/4885KDM4E 3377/4885ALDH1A1 1578/4885
US-20180134718-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, SLCO4C1 HPGD 1331/4885KDM4E 3377/4885ALDH1A1 1578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.